Overview

Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination

Status:
Completed
Trial end date:
2016-12-21
Target enrollment:
0
Participant gender:
All
Summary
The main objective of this study is to record, in routine clinical practice, patients' adherence to treatment with Perindopril/Indapamide/Amlodipine fixed dose combination, during 4 months treatment.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Servier Hellas Pharmaceuticals Ltd.
Treatments:
Amlodipine
Indapamide
Perindopril
Criteria
Inclusion Criteria:

- Male or female, ambulatory patients >18 years old.

- Clinically diagnosed essential arterial hypertension.

- Under treatment with Perindoril/Indapamide/Amlodipine fixed dose combination.

- The patient has given his/her written consent after being informed, before his
inclusion in the study.

Exclusion Criteria:

- Secondary arterial hypertension.

- Serious end stage diseases, severe neuropsychiatric diseases, cerebrovascular event
with serious residual lesions, scheduled procedure or surgical operation or hospital
admission.

- Pregnancy, lactation or intention to become pregnant.